Kestine (Ebastine)

Ebastine acts as a selective peripheral H1‑receptor antagonist. By binding to H1 receptors on mast cells and other tissues, it blocks histamine from triggering the inflammatory cascade that causes vasodilation, increased permeability, and sensory nerve activation, thereby mitigating allergic symptoms.

The appropriate dose of Kestine is determined by the prescribing healthcare professional based on the patient’s age, weight, renal and hepatic function, and the severity of the allergic condition. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Ebastine is classified as Pregnancy Category B, indicating that animal studies have not shown risk to the fetus, but there are no adequate human studies. It may be used during pregnancy only if the potential benefit justifies the potential risk. Caution is advised while breastfeeding; the infant should be monitored for any adverse effects.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Kestine. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with first‑generation antihistamines, ebastine (Kestine) offers effective relief of allergic symptoms with a lower risk of sedation because it does not readily cross the blood‑brain barrier. It is similar in efficacy to other second‑generation agents such as cetirizine or loratadine, but individual response and tolerability may vary.

Kestine should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, excessive heat and direct sunlight to maintain stability and potency throughout its shelf life.

Kestine is taken orally, usually with a glass of water. The tablet (or capsule) should be swallowed whole and not chewed or crushed, unless the prescriber provides specific instructions for a particular patient population.

While generally well tolerated, serious adverse events can include cardiac arrhythmias, severe skin reactions such as Stevens‑Johnson syndrome, anaphylactic reactions, and rare cases of liver injury. Patients should seek immediate medical attention if they experience symptoms like rash, difficulty breathing, chest pain, or jaundice.

Kestine is contraindicated in individuals with known hypersensitivity to ebastine or any of the tablet’s excipients. It should also be avoided in patients with a history of severe cardiac arrhythmias or severe hepatic impairment unless specifically directed by a qualified healthcare professional.